Latest Breaking News On - விஞ்ஞானிகள் மன்றம் - Page 10 : comparemela.com

Centre s COVID-19 Vaccine Plan Will Lead To Profiteering By Private Companies

A health worker holds a vial with doses of Covishield in Paramaribo, Suriname, February 23, 2021. Photo: REUTERS/Ranu Abhelakh New Delhi: A national association of doctors and scientists have accused the Centre of lending the COVID-19 vaccination drive to “profiteering” by private companies rather than ensuring public financing of the programme. In a statement, the Progressive Medicos and Scientists Forum said on Wednesday that the Centre’s move is “bound to lend the vaccine prices to market manipulation for maximising private profits”. “Rather than ensuring entirely public financing of vaccination, which makes far better epidemiological and economic sense, the government has lent even the vaccination drive to profiteering by private companies by announcing that 50 per cent of all the doses shall now be routed through the open market.”

New delhiRanu abhelakhScientists forumCentral drugs laboratoryProgressive medicosபுதியது டெல்ஹிவிஞ்ஞானிகள் மன்றம்மைய மருந்துகள் ஆய்வகம்ப்ரோக்ரெஸிவ் மருந்துகள்

Doctors, Scientists Say Centre s COVID Vaccine Rollout Plan Leads to Profiteering

Doctors, Scientists Say Centre s COVID Vaccine Rollout Plan Leads to Profiteering
thewire.in - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thewire.in Daily Mail and Mail on Sunday newspapers.

New delhiScientists forumCentral drugs laboratoryProgressive medicosபுதியது டெல்ஹிவிஞ்ஞானிகள் மன்றம்மைய மருந்துகள் ஆய்வகம்ப்ரோக்ரெஸிவ் மருந்துகள்

The Vaccine Row in India explained: between a jab and a hard place

The âVaccine Rowâ in India explained: between a jab and a hard placeÂ Every country is facing challenges in the race to get COVID-19 vaccines to millions of people, but with the ruling class staying away from public inoculation in India, a vaccine row has broken out Engagement: 0 On December 21, US President Joe Biden rolled up a sleeve and smiled at television cameras as he received a Covid-19 jab. âI urge you to take it. There is nothing to worry about,â tweeted the 78-year-old. In Israel, Prime Minister Benjamin Netanyahu, 71, took a shot on television, to encourage his country. Days later, Britainâs Queen Elizabeth, 94, and Prince Philip, 99, received theirs at Windsor Castle. At Vatican, Pope Francis, 84, took his shot and told reporters: âIt is a moral choice. It is about your life but also the lives of others.â

Anandpur sahibTej pratap yadavPriyank khargeManish tewariAkhilesh yadavUniversity of oxfordScientists forumSamajwadi partySerum institute of indiaPrime ministerProgressive medicosSerum instituteNovel coronavirusCovid 19Covid 19 vaccineஆனந்த்பூர் சாஹிப்

Safety fears hamper India s COVID-19 vaccination drive

NEW DELHI: The world’s biggest vaccination drive to inoculate 1.3 billion people against the coronavirus is slowing down in India as concerns over safety fuel vaccine hesitancy, especially among health workers.

Adarsh pratap singhNirmalya mohapatraNarendra modiRam manohar lohiaHarjit singh bhattialsoAmar jesaniScientists forumSerum institute of indiaIndia institute of medical sciencesHealth ministryResident doctors associationPrime minister narendra modiPratap singhDelhi based all india instituteMedical sciencesArab news

Known good: efficacy of Covid vaccines

The need for inoculation against Covid-19 as soon as possible cannot be denied. But no vaccine should be administered without the recipient’s trust and conviction that are based on full information about its efficacy. Only then can there be informed consent; its absence regarding the two vaccines being administered across India is disturbing. The Progressive Medicos and Scientists Forum, a national association, formulated the requirements that would set at rest the doubts and fears of concerned citizens. The forum stated that all data pertaining to clinical trials of both vaccines should be made available to scientists and healthcare workers so that they can make informed choices. The data from Phase III trials should be transparently presented as and when they become available, and the decision to grant emergency use authorization could then be reconsidered. Since it is Covaxin, the indigenous vaccine, that has not completed Phase III trials but has received EUA, the thrust of the

Scientists forumProgressive medicosவிஞ்ஞானிகள் மன்றம்ப்ரோக்ரெஸிவ் மருந்துகள்